Akira Hori

Akira Hori is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of therapeutic drugs, particularly in the development of peptides that target specific biological pathways. His work focuses on addressing critical health issues such as cancer and chronic rheumatoid arthritis.

Latest Patents

Hori holds 3 patents related to his innovative research. His latest patents include a CXCR4 antagonist and its use in therapeutic drugs for cancer and chronic rheumatoid arthritis. These patents describe peptides that exhibit CXCR4 antagonism, along with their amides, esters, and salts. The therapeutic effects of these compounds are aimed at improving treatment outcomes for patients suffering from these serious conditions.

Career Highlights

Hori's career is marked by his dedication to advancing medical science through innovative drug development. His work at Biokine Therapeutics Ltd. has positioned him as a key player in the biotechnology sector. His research has the potential to lead to groundbreaking treatments that can significantly impact patient care.

Collaborations

Hori collaborates with esteemed colleagues, including Nobutaka Fujii and Hirokazu Tamamura. These partnerships enhance the research efforts at Biokine Therapeutics Ltd. and contribute to the advancement of therapeutic innovations.

Conclusion

Akira Hori's contributions to the field of therapeutic peptides are noteworthy. His innovative patents and collaborative efforts are paving the way for new treatments in oncology and rheumatology. His work exemplifies the impact of dedicated research on improving health outcomes for patients worldwide.

Profile summary based on public USPTO records.